Extravasation of sclerosant after injection of N-butyl-2-cyanoacrylate for a bleeding gastric Dieulafoy lesion.
Soon
M-S
MS
Department of Gastroenterology, Changhua Christian Medical Center, Changhua, Taiwan, ROC.
Chen
Y-Y
YY
Yen
H-H
HH
D000368:Aged; D004659:Enbucrilate / Q000009:adverse effects / Q000627:therapeutic use*; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000000981:diagnostic imaging* / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D020252:Gastric Antral Vascular Ectasia / Q000175:diagnosis / Q000628:therapy*; D006471:Gastrointestinal Hemorrhage / Q000175:diagnosis / Q000628:therapy*; D005773:Gastroscopy / Q000379:methods; D006801:Humans; D015552:Injections, Intralesional; D008026:Ligation / Q000379:methods; D013902:Radiography, Thoracic; D012008:Recurrence; D019233:Retreatment; D018570:Risk Assessment; D012597:Sclerosing Solutions / Q000008:administration & dosage / Q000009:adverse effects*; D015911:Sclerotherapy / Q000009:adverse effects* / Q000379:methods; D014057:Tomography, X-Ray Computed
D012597:Sclerosing Solutions; D004659:Enbucrilate